HomeSearchDiabetes, Metabolic Syndrome and Obesity

Diabetes, Metabolic Syndrome and Obesity

Dove Medical Press Ltd · New Zealand · Est. 2008

ISSN1178-7007eISSN1178-7007
SJR Q2WOS SCIEScopus / SJRDOAJOpen Access
Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

📊 Standing in its field
Where this journal ranks among others in the same subject area.
Q2
SJR · Scopus
Top 50% in field
Clarivate’s JCR quartile is a separate ranking and may differ
SJR Scorei
0.89
H-Indexi
95
SNIPi
0.842
Total Worksi
3,428
Total Citationsi
64,333
2yr Mean Citednessi
2.80
Open Impact Factor alternative
Retractions
1
Source: Retraction Watch

Aims & Scope

The journal is committed to the rapid publication of the latest laboratory and clinical findings that lead to establishing new paradigms in the diagnosis, treatment or prevention of diabetes, metabolic syndrome, or obesity. The journal welcomes original research manuscripts, reviews, expert opinions, and commentaries relating to all aspects of obesity, diabetes, and metabolic syndrome.

General Information

Country / RegionNew Zealand
Primary LanguageEnglish
1st Year Published2008
Annual Volume~ 396 articles / year
StatusActive (last: 2026)
Total Publications3,428
Publisher OrgDove Medical Press
OA Since2007
Visit Journal Website

Submission Info

Peer ReviewSingle-blind
OA LicenseCC BY, CC BY-NC
OA Rate

Ethics & Quality

COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes
Plagiarism Detection✓ Yes
📦 Long-term Preservation
PMCCLOCKSS

Think.Check.Submit Compliance

10/11 · 91%
Do you know the journal / publisher?
Dove Medical Press Ltd
Does the journal have a website?
✓ Linked
Is the ISSN verified?
1178-7007 / 1178-7007
Indexed in a trusted database?
WoS, Scopus, DOAJ, PubMed
Peer review process documented?
Single-blind
Follows ethical publishing standards (COPE)?
N/A
Not on predatory/blacklists?
✓ Clean
Long-term digital preservation?
PMC, CLOCKSS
Plagiarism detection in place?
Yes
Listed in DOAJ (verified OA)?
DOAJ verified
Primary language documented?
English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
260
8.5k
2019
489
12k
2020
449
8.1k
2021
350
4.9k
2022
373
4k
2023
426
2.6k
2024
389
964
2025
194
47
2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Internal MedicineQ2
PharmacologyQ2

Subject Classification

Web of Science Categories

Endocrinology & Metabolism

Scopus Categories

Internal MedicinePharmacology

Research Topics (OpenAlex)

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and ManagementAdipokines, Inflammation, and Metabolic DiseasesDiabetes Management and ResearchLiver Disease Diagnosis and TreatmentDiabetes Management and EducationChronic Kidney Disease and DiabetesMetabolism, Diabetes, and CancerBariatric Surgery and OutcomesDiet and metabolism studies

Frequently asked questions about Diabetes, Metabolic Syndrome and Obesity

Is Diabetes, Metabolic Syndrome and Obesity a predatory journal?

PubScope has no integrity flags on record for Diabetes, Metabolic Syndrome and Obesity: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Diabetes, Metabolic Syndrome and Obesity?

Diabetes, Metabolic Syndrome and Obesity is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 2.80.

Is Diabetes, Metabolic Syndrome and Obesity indexed in Scopus and Web of Science?

Diabetes, Metabolic Syndrome and Obesity is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Diabetes, Metabolic Syndrome and Obesity?

The journal is committed to the rapid publication of the latest laboratory and clinical findings that lead to establishing new paradigms in the diagnosis, treatment or prevention of diabetes, metabolic syndrome, or obesity. The journal welcomes original research manuscripts, reviews, expert opinions, and commentaries relating to all aspects of obesity, diabetes, and metabolic syndrome.

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref